Last updated: 27 February 2020 at 6:50pm EST

Sylvia Cheung Net Worth




The estimated Net Worth of Sylvia Cheung is at least $1.73 Million dollars as of 6 November 2019. Sylvia Cheung owns over 35,000 units of Anika Therapeutics stock worth over $1,731,984 and over the last 11 years Sylvia sold ANIK stock worth over $0.

Sylvia Cheung ANIK stock SEC Form 4 insiders trading

Sylvia has made over 4 trades of the Anika Therapeutics stock since 2015, according to the Form 4 filled with the SEC. Most recently Sylvia exercised 35,000 units of ANIK stock worth $222,600 on 6 November 2019.

The largest trade Sylvia's ever made was exercising 35,000 units of Anika Therapeutics stock on 6 November 2019 worth over $222,600. On average, Sylvia trades about 3,438 units every 97 days since 2014. As of 6 November 2019 Sylvia still owns at least 71,422 units of Anika Therapeutics stock.

You can see the complete history of Sylvia Cheung stock trades at the bottom of the page.



Insiders trading at Anika Therapeutics

Over the last 21 years, insiders at Anika Therapeutics have traded over $58,649,775 worth of Anika Therapeutics stock and bought 34,227 units worth $758,329 . The most active insiders traders include Charles H Sherwood, Farmaceutici S.P.A. Fidia, and Joseph H Capper. On average, Anika Therapeutics executives and independent directors trade stock every 47 days with the average trade being worth of $613,258. The most recent stock trade was executed by Cheryl R Blanchard on 11 March 2024, trading 64,480 units of ANIK stock currently worth $1,563,640.



What does Anika Therapeutics do?

who we are we are anika therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. we are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. with over 7 million procedures performed over the past twenty years utilizing our proprietary technology, anika is helping individuals all over the world return to life naturally. our guiding principles we are innovators and creators. we value strong discipline and exceptional focus from our personnel, and we employ lean principles and agile processes in managing our business. this foundation of guiding values, combined with our entrepreneurial spirit, gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care an



Complete history of Sylvia Cheung stock trades at Anika Therapeutics

Insider
Trans.
Transaction
Total value
Sylvia Cheung
Chief Financial Officer
Option $222,600
6 Nov 2019
Sylvia Cheung
Chief Financial Officer
Option $89,900
22 Feb 2017
Sylvia Cheung
Chief Financial Officer
Option $63,050
31 Jul 2015
Sylvia Cheung
Chief Financial Officer
Option $63,050
31 Jul 2015


Anika Therapeutics executives and stock owners

Anika Therapeutics executives and other stock owners filed with the SEC include: